WCN24-2023 SWITCHING TO CKD-EPI LEADS TO UNDERDIAGNOSING CKD IN A COMMUNITY-BASED MEXICAN COHORT OF ADOLESCENTS AND YOUNG ADULTS - A CROSS-SECTIONAL STUDY

WCN24-2023 SWITCHING TO CKD-EPI LEADS TO UNDERDIAGNOSING CKD IN A COMMUNITY-BASED MEXICAN COHORT OF ADOLESCENTS AND YOUNG ADULTS - A CROSS-SECTIONAL STUDY

Saved in:

Bibliographic Details
Main Authors:	Alethia Paulina Monserrat Guzmán Núñez, Guido Filler, Ajay P. Sharma, Olivier C. Barbier, Elodia Rojas Lima, Pablo Mendez-Hernández, Manolo Ortega-Romero, Maria Esther Díaz González de Ferris, Mara Medeiros
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924002973
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2832 COMPARISON OF ESTIMATED GLOMERULAR FILTRATION RATE IN MEXICAN KIDNEY TRANSPLANT RECIPIENTS: A COMPARATIVE ANALYSIS OF MDRD AND CKD-EPI EQUATIONS
by: Milagros Melissa Flores Fonseca, et al.
Published: (2025-02-01)

Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians
by: Boon Wee Teo, et al.
Published: (2014-01-01)

No Race-Ethnicity Adjustment in CKD-EPI Equations Is Required for Estimating Glomerular Filtration Rate in the Brazilian Population
by: Amanda D. Rocha, et al.
Published: (2020-01-01)

Inside CKD: Cost-Effectiveness of Multinational Screening for CKD
by: Navdeep Tangri, et al.
Published: (2025-04-01)

Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, Canada
by: Mohammad Atiquzzaman, et al.
Published: (2024-04-01)

Performance of the 2021 Estimated Glomerular Filtration Rate CKD-EPI Refit and the European Kidney Function Consortium (EKFC) Formulas
by: Evelyn O. Ilori, et al.
Published: (2025-04-01)

Anemia in Pregnancy With CKD
by: Margriet F.C. de Jong, et al.
Published: (2024-05-01)

Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study
by: Michael B. Sohn, et al.
Published: (2024-03-01)

Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD
by: Naveen Rao, et al.
Published: (2025-07-01)

Low Energy Diets for Obesity and CKD (SLOW-CKD Randomized Feasibility Study)
by: Marguerite M. Conley, et al.
Published: (2025-07-01)

Evaluation of CRP SNV rs2808630 and acute proinflammatory biomarkers in patients with CKD and PLHIV with CKD: a case-control study
by: Andrea Torres-Rojas, et al.
Published: (2025-05-01)

The Promise of Dotinurad for Hyperuricemia in CKD
by: Amy S. Li, et al.
Published: (2025-06-01)

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study
by: Jihyun Yang, et al.
Published: (2024-10-01)

CKD Knowledge and CKD Report Card Use During a Nephrology Encounter: A Randomized Trial
by: Jillian Bowman, et al.
Published: (2025-05-01)

Validation of the EKFC equation for glomerular filtration rate estimation and comparison with the Asian-modified CKD-EPI equation in Chinese chronic kidney disease patients in an external study
by: Li Zhao, et al.
Published: (2023-12-01)

Impact of CKD on Female Reproductive Hormones
by: Mahua Bhaduri, et al.
Published: (2025-07-01)

Optimizing osteoporosis management in CKD patients
by: Yong Wang, et al.
Published: (2025-04-01)

New Obesity Guidelines and Implications for CKD
by: Tilman B. Drueke, et al.
Published: (2025-05-01)

Updates on New Therapies for Patients with CKD
by: Tushar Tarun, et al.
Published: (2024-01-01)

Barriers to Care: New Medications and CKD
by: Dana Kim, et al.
Published: (2024-03-01)

Framework of Guidelines for Management of CKD in Asia
by: Carol Pollock, et al.
Published: (2024-04-01)

Safety of Drugs in Breastfeeding Women With CKD
by: Paula Parnizari, et al.
Published: (2025-07-01)

Association of Phenylacetylglutamine and Cognitive Impairment in CKD
by: Hélène Levassort, et al.
Published: (2025-08-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
by: Soon Kyu Lee, et al.
Published: (2025-01-01)

Metronidazole-induced cerebellar dysfunction: An underdiagnosed identity
by: Aditya Debuka, et al.
Published: (2025-07-01)

Re: Activated Omentum Slows Progression of CKD
by: Fehmi Narter
Published: (2018-12-01)

Mitochondrial Dysfunction: The Nexus of Aging, Dyslipidemia, and CKD
by: Yu-Hsiang Lin, et al.
Published: (2025-03-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

Risk Stratification for CKD Progression in Primary Care
by: Clyson Mutatiri, et al.
Published: (2025-05-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

Research on CKD-MBD from the Prospective of TCM
by: WANG Xiao-qin, et al.
Published: (2020-01-01)

In response to optimizing osteoporosis management in CKD patients
by: Jordi Bover, et al.
Published: (2025-04-01)

CKD: A Guide to Higher Fiber Foods
by: Wendy J. Dahl, et al.
Published: (2018-01-01)

CKD of Unknown Etiology: Is Taiwan Another Hotspot?
by: Isabelle Dominique Tomacruz Amante, et al.
Published: (2024-01-01)

The Important Role of Sleep in CKD Prevention and Progression
by: Ginger Chu, et al.
Published: (2025-06-01)

Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01)

Longitudinal Lipid Trajectories and Progression of CKD in Children
by: Uwe Querfeld, et al.
Published: (2025-05-01)

Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD
by: Katsuyuki Tanabe, et al.
Published: (2025-06-01)

Risk Factors for Progression of CKD with and without Diabetes
by: Xiaohong Zhang, et al.
Published: (2022-01-01)